fbpx
September 26, 2024

Emapalumab Effective in Rheumatologic Disease–Associated HLH Emapalumab Effective in Rheumatologic Disease–Associated HLH

TOPLINE: Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH). METHODOLOGY: Researchers conducted […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0